List of Publications apl. Prof. Dr. Cornelia Blume
Showing results 61 - 70 out of 88
2013
Blume, C. (2013). Immunsuppression nach Nierentransplantation: Was ist die Empfehlung für die Zukunft? Nieren- und Hochdruckkrankheiten, 42(12), 552-560. https://doi.org/10.5414/NHX01575
Blume, C., & Brunkhorst, R. (2013). Nieren- und Hochdruckkrankheiten: Editorial. Nieren- und Hochdruckkrankheiten, 42(12), 521-522. https://doi.org/10.5414/NHX01571
Hess, R., Dunkel, A., Chatzikyrkou, C., & Blume, C. (2013). Mehr Transparenz bei der Vermittlung von Nierentransplantaten. Nieren- und Hochdruckkrankheiten, 42(12), 539-544. https://doi.org/10.5414/NHX01577
Neudoerfl, C., Mueller, B. J., Blume, C., Daemen, K., Stevanovic-Meyer, M., Keil, J., Lehner, F., Haller, H., & Falk, C. S. (2013). The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs. Frontiers in Immunology, 4(FRB), Article Article 46. https://doi.org/10.3389/fimmu.2013.00046
Pape, L., Lämmermühle, J., Oldhafer, M., Blume, C., Weiss, R., & Ahlenstiel, T. (2013). Different models of transition to adult care after pediatric kidney transplantation: A comparative study. Pediatric Transplantation, 17(6), 518-524. https://doi.org/10.1111/petr.12102
2012
Blume, C., Felix, A., Shushakova, N., Gueler, F., Falk, C. S., Haller, H., & Schrader, J. (2012). Autoimmunity in CD73/Ecto-5′-nucleotidase deficient mice induces renal injury. PLoS ONE, 7(5), Article e37100. https://doi.org/10.1371/journal.pone.0037100
2011
Chatzikyrkou, C., Menne, J., Gwinner, W., Schmidt, B. M., Lehner, F., Blume, C., Schwarz, A., Haller, H., & Schiffer, M. (2011). Pathogenesis and management of hypertension after kidney transplantation. Journal of Hypertension, 29(12), 2283-2294. https://doi.org/10.1097/HJH.0b013e32834bd1e7
Habicht, A., Bröker, V., Blume, C., Lorenzen, J., Schiffer, M., Richter, N., Klempnauer, J., Haller, H., Lehner, F., & Schwarz, A. (2011). Increase of infectious complications in ABO-incompatible kidney transplant recipients: A single centre experience. Nephrology Dialysis Transplantation, 26(12), 4124-4131. https://doi.org/10.1093/ndt/gfr215
Pape, L., Lehner, F., Blume, C., & Ahlenstiel, T. (2011). Pediatric kidney transplantation followed by de novo therapy with everolimus, low-dose cyclosporine a, and steroid elimination: 3-Year Data. Transplantation, 92(6), 658-662. https://doi.org/10.1097/TP.0b013e3182295bed
2009
Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L. S., Mysler, E., Sánchez-Guerrero, J., Solomons, N., Wofsy, D., Abud, C., Adler, S., Alarcón, G., Albuquerque, E., Almeida, F., Alvarellos, A., Appel, G., Avila, H., ... Zoruba, D. (2009). Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. Journal of the American Society of Nephrology, 20(5), 1103-1112. https://doi.org/10.1681/ASN.2008101028
